Pralatrexate and its Impurities
Pralatrexate is used to treat a certain type of cancer known as Peripheral T-Cell Lymphoma. It is an anti-cancer therapy.Reference standards of Pralatrexate API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
(4-(2-((2,4-Diaminopteridin-6-yl)methyl)-1-(2-methoxyethoxy)-1-oxopent-4-yn-2-yl)benzoyl)-L-glutamic Acid
(4-(2-((2,4-Diaminopteridin-6-yl)methyl)-1-(2-methoxyethoxy)-1-oxopent-4-yn-2-yl)benzoyl)-L-glutamic Acid
Catalogue No.:PA 16 2621006
CAS :
NA
Molecular Formula : C27H29N7O8
Molecular Weight : 579.57
(2S)-2-(4-(1-(2,4-diaminopteridin-6-yl)pent-4-yn-2-yl)benzamido)-5-methoxy-5-oxopentanoic acid
(2S)-2-(4-(1-(2,4-diaminopteridin-6-yl)pent-4-yn-2-yl)benzamido)-5-methoxy-5-oxopentanoic acid
Catalogue No.:PA 16 2621008
CAS :
1548618-62-7
Molecular Formula : C24H25N7O5
Molecular Weight : 491.51